|
|
News Breaks | | | | October 12, 2012 | | 07:30 EDT |  | CELG | FDA PDUFA Date for Celgene's Abraxane
The FDA assigned a Prescription Drug User Fee Act (PDUFA) action date for the review of Celgene's supplemental New Drug Application (sNDA) for Abraxane for treatment of non-small cell lung cancer of October 12, 2012. | |
|
News For CELG From The Last 14 Days Check below for free stories on CELG the last two weeks. |
|
|
| May 24, 2013 | | 07:20 EDT |  | CELG | Celgene, Gilead, and Biogen could go much higher, says Bernstein
 Subscribe for More Information | | | May 23, 2013 | | 07:37 EDT |  | CELG | Celgene says FDA grants priority review for ABRAXANE sNDA
Subscribe for More Information | | | May 20, 2013 | | 09:51 EDT | | CELG | Celgene management to meet with JPMorgan
Meetings to be held in Boston on May 22-23 hosted by JPMorgan. | | | May 17, 2013 | | 05:51 EDT |  | CELG | Stocks with implied volatility movement; CBST CELG
Subscribe for More Information | | | May 16, 2013 | | 11:50 EDT | | CELG | Celgene, Gilead lower after new data published at ASCO
Subscribe for More Information | |
|
|
|
|
|
|
